These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36730833)

  • 1. Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.
    Isidro RA; Abukhiran I; Dunseth CD; Gosse MD; Humble RM; Pelletier DJ; Varshney N; Bellizzi AM; Hornick JL
    Am J Surg Pathol; 2023 Apr; 47(4):440-452. PubMed ID: 36730833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system.
    Lu SH; Yuan RH; Chen YL; Hsu HC; Jeng YM
    Histopathology; 2013 Nov; 63(5):640-8. PubMed ID: 24024557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels.
    Kälsch J; Padden J; Bertram S; Pott LL; Reis H; Westerwick D; Schaefer CM; Sowa JP; Möllmann D; Fingas C; Dechȇne A; Sitek B; Eisenacher M; Canbay A; Ahrens M; Baba HA
    Virchows Arch; 2017 May; 470(5):537-543. PubMed ID: 28357490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells.
    Padden J; Ahrens M; Kälsch J; Bertram S; Megger DA; Bracht T; Eisenacher M; Kocabayoglu P; Meyer HE; Sipos B; Baba HA; Sitek B
    Mol Cell Proteomics; 2016 Mar; 15(3):1072-82. PubMed ID: 26644413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Annexin A10 expression is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
    Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Yamaguchi A; Kuwai T; Sudo T; Hadano N; Tashiro H; Taniyama K; Yasuif W
    Histol Histopathol; 2022 Mar; 37(3):243-250. PubMed ID: 34821375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HNF6 and HNF4α expression in adenocarcinomas of the liver, pancreaticobiliary tract, and gastrointestinal tract: an immunohistochemical study of 480 adenocarcinomas of the digestive system.
    Toriyama K; Uehara T; Iwakoshi A; Kawashima H; Hosoda W
    Pathology; 2024 Oct; 56(6):804-813. PubMed ID: 38926048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.
    Karanjawala ZE; Illei PB; Ashfaq R; Infante JR; Murphy K; Pandey A; Schulick R; Winter J; Sharma R; Maitra A; Goggins M; Hruban RH
    Am J Surg Pathol; 2008 Feb; 32(2):188-96. PubMed ID: 18223320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma.
    Shao YY; Kuo HY; Jeng YM; Wu YM; Wang HP; Hsu C; Hsu CH; Hsu HC; Cheng AL; Lin ZZ
    BMC Cancer; 2022 Feb; 22(1):219. PubMed ID: 35227227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
    APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
    Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P
    Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.
    Hooper JE; Morgan TK; Grompe M; Sheppard BC; Troxell ML; Corless CL; Streeter PR
    Hum Pathol; 2012 Oct; 43(10):1583-9. PubMed ID: 22406361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxymethylcytosine (5-hmC) loss is a marker of malignancy in biliary neoplasms.
    Gonzalez-Mancera MS; Siref A; Kosari K; Nissen N; Gaddam S; Hendifar A; Osipov A; Waters K; Hutchings D; Guindi M; Larson BK
    Am J Clin Pathol; 2024 Jul; 162(1):41-50. PubMed ID: 38345293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma.
    Moy AP; Arora K; Deshpande V
    Histopathology; 2016 Sep; 69(3):423-30. PubMed ID: 26841202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A10 is involved in the induction of pancreatic duodenal homeobox‑1 in gastric cancer tissue, cells and organoids.
    Ishikawa A; Sakamoto N; Honma R; Taniyama D; Fukada K; Hattori T; Sentani K; Oue N; Yanagihara K; Tanabe K; Ohdan H; Yasui W
    Oncol Rep; 2020 Feb; 43(2):581-590. PubMed ID: 31789399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma.
    Tsai JH; Lin YL; Cheng YC; Chen CC; Lin LI; Tseng LH; Cheng ML; Liau JY; Jeng YM
    Mod Pathol; 2015 Feb; 28(2):268-78. PubMed ID: 25081749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-complex-associated-testis-expressed 3 (TCTE3) is a novel marker for pancreatobiliary carcinomas.
    Zhao CL; Hui Y; Wang LJ; Lombardo K; Yang D; Mangray S; Yakirevich E; Amin A; Huang CK; Lu S
    Hum Pathol; 2017 Dec; 70():62-69. PubMed ID: 29079176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Biomarker Panels Discriminating between Pancreatic Ductal Adenocarcinoma and Extrahepatic Bile Duct Carcinoma.
    Noh BJ; Choi GM; Jang HJ; Ma CH; Oh HS; Kim M; Eom DW
    Ann Clin Lab Sci; 2022 Mar; 52(2):323-331. PubMed ID: 35414511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma.
    Yumura M; Nagano T; Jimbo N; Dokuni R; Kiriu T; Tanaka Y; Tachihara M; Itoh T; Maniwa Y; Nishimura Y; Kobayashi K
    Anticancer Res; 2022 Mar; 42(3):1289-1294. PubMed ID: 35220218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.